PG_INDIA 2026_4

MODI PRIX GALIEN INDIA

The 2026 vintage of the Modi Prix Galien India Awards brought forth seven exciting winning innovations.

“The awards are a reminder of the immense progress of India’s health ecosystem and we look forward to seeing the continued impact of these innovations in years to come,” stated Prof Ashutosh Sharma, Committee Chair and Former President of the Indian National Science Academy.

The awards were preceded by the annual Galien India Forum where the most challenging issues facing Indian life science innovation from AI innovation through to human dignity and global macros were debated.

RELIVE THE MOMENTS

India is scaling its position as a key player in the production of medicines both in sheer volume and in value worldwide ensuring accessibility to treatment. Many exciting treatments and technologies are being developed in India today including innovative biologics with tremendous potential to treat and cure disease on a global scale.

“It is a great pride to see India's innovation ecosystem recognized on the global stage. The Modi Prix Galien reflects our shared commitment to advancing science, improving patient outcomes, and fostering a healthier future for all,” said Sir Satish Kumar Modi, President of the Modi Galien Foundation India.

“We are delighted to return to India for the third year of the Modi Prix Galien India Awards and extend our congratulations to this year's prestigious cohort of winners whose efforts are shaping the future of health and life science innovation,” said Bruno Cohen, Chairman of The Galien Foundation.

Best Biotechnology Product

Twinrab - Zydus Lifesciences Ltd

Best Pharmaceutical Product

Kerendia^® - Bayer Pharmaceuticals
Pvt Ltd

Best Product for Rare/Orphan Diseases

Alhemo^® - Novo Nordisk

Best Academic / Public Sector

NeuroInnovate - AIIMS+IITD Neuro-
Engineering Collaboration

Best Medical Technology

Myval THV Series - Meril

Best Digital Health Solution

Visit Health - Visit Health Private
Limited

Best Startup

M-Strip: Path-Breaking
Innovation in Cervical
Cancer Screening - IOTA Diagnostic Private
Limited

PG India 2026 - Zydus

Best Biotechnology Product - PGI 2026 Laureate: Zydus Lifesciences Ltd for Twinrab

PG India 2026 - Bayer

Best Pharmaceutical Product - PGI 2026 Laureate: Bayer Pharmaceuticals
Pvt Ltd for Kerendia^®

PG India 2026 - NovoNordics

Best Product Academic/Public Sector - PGI 2026 Laureate: Novo Nordisk for Alhemo^®

PG India 2026 - NeuroInnovate

Best Academic / Public Sector Innovation - PGI 2026 Laureate: AIIMS+IITD Neuro-Engineering Collaboration for NeuroInnovate

PG India 2026 - Merill

Best Medical Technology - PGI 2026 Laureate: Meril for Myval THV Series

PG India 2026 - Visit Health

Best Digital Health Solution - PGI 2026 Laureate: Visit Health Private Limited for Visit Health

PG India 2026 - IOTA

Best Startup - PGI 2026 Laureate: IOTA Diagnostic Private Limited for M-Strip: Path-Breaking Innovation in Cervical Cancer Screening

Mr. Jadhav Prataprao Ganpatrao, Union Minister of State for Health and Family Welfare, Government of India

AWARDS_15

Satish Kumar Modi, Co-Founder of Modi Prix Galien India

AWARDS_17

Bruno Cohen, Galien Foundation Chairman

AWARDS_2-1

Actress Mandira Bedi emcee of the Modi Prix Galien 2025 ceremony

AWARDS_16

Modi Prix Galien India Awards Ceremony 2025

AWARDS_8

Modi Prix Galien India Awards Ceremony 2025

PG India 2026 - Forum 4

Panel "AI & Clinical Trials: Accelerating Equitable Health Innovation"
(l to r): Harish Iyer (Moderator), Dr Digambar Behera, Prof Narinder Kumar Mehra, Dr Shirshendu Mukherjee

PG India 2026 - Forum 2

Panel "AI in Action: Building India's Scalable, Trusted Health Innovation System"
(l to r): Dr. Anurag Agarwal (Moderator), Dr. Subi Chaturvedi, Kshitij Jadhav, Mr. Vivek Raj, Mr. Umakant Soni

PG India 2026 - Forum 1

Panel "AI, Human Dignity & Global Health: From Ethical Foundations To Scalable Innovation"
(l to r): Fr. Paolo Benanti (Moderator), Dr. Dominique J. Monlezun, Pr. Gifty Immanuel, Mr. Pranav Sopory, Andrea Ciucci

PG India 2026 - AI Ethics agreement

Father Andrea Ciucci, PhD STB and Sir Satish Kumar Modi

JURY MEMBERS:

Dr Rajeev Ahuja, Director IIT, Ropar

Dr Digamber Behra, Padma Shri President, National Academy of Medical Sciences

Dr Subi Chaturvedi, SVP & Chief Corporate Affairs & Public Policy Officer, InMobi

Dr Alok Dhawan, Centre for Biomedical Research, Lucknow

Shri Anil Khanna, Sr. Vice President, GM Modi Science Foundation, New Delhi

Dr Indranil Manna, President, Indian National Academy of Engineering

Dr Narinder Kumar Mehra, Vice-President, International Affairs Indian National Science Academy

Prof Ashwani Nangia, Department of Chemistry, University of Hyderabad

Dr Prashant Parkash, Padma Shri Founding Partner, Accel India; Chairman, Karnataka’s Vision Group for Startups

Dr JD Patil, President, Indian National Academy of Engineering

Dr Padmaja Ruparel, President, Indian Angel Network & Managing Partner, IAN Fund

Dr Dipankar Das Sarma, Solid State and Structural Chemistry Unit, Indian Institute of Science, Bangalore

Prof Anurag Sharma, IIT Delhi

Dr Sanjay Singh, Chief Executive Officer, Gennova Biopharmaceuticals Ltd., Pune

Dr Rohit Srivastava, IIT Mumbai

Dr Umesh Waghmare, President, Indian Academy of Science, Bangalore

SUB-COMMITTEE-I - BIOTECH PRODUCT / PRODUCT FOR ORPHAN / RARE DISEASES

Dr Anurag Agrawal, Former Director, Institute of Genomics and Integrative Biology (CSIR)

Dr Sudha Bhattacharya, The National Academy of Sciences of India

Prof Alok Dhawan, Director, Centre of BioMedical Research, Lucknow

Sonia Gandhi, GM, Biotechnology Industry Research Council

Dr Arbinda Mitra, Former Scientific Secretary, Office of the Principal Scientific Adviser to the Government of India

Dr Shirshendu Mukherjee, Medical Microbiologist, Managing Director - Wadhwani Foundation

Dr Arvind Sahu, Director, Regional Centre for Biotechnology, Faridabad

Dr Shashi Bala Singh, Director, NIPER, Hyderabad

Prof Nikhil Tandon, AIIMS, New Delhi

Dr Anil Kumar Tripathi, Director, IISER Mohali

Dr Harikrishan Verma, Regional Research Laboratory (CSIR)

Prof Sudhanshu Vrati, Former Executive Director, Regional Centre for Biotechnology / ex-RCB Faridabad

SUB-COMMITTEE-II - MEDICAL TECHNOLOGY (INCLUDING DIAGNOSTIC TOOLS) / STARTUP / DIGITAL HEALTH SOLUTION / INCUBATOR-ACCELERATOR

Dr Subi Chaturvedi, SVP & Chief Corporate Affairs & Public Policy Officer, InMobi

Dr Gobardhan Das, Director, The Indian Institute of Science Education and Research, Bhopal

Dr Keshav Deo, CMD, Lifeactivus Pvt Ltd

Dr Debasisa Mohanty, Director, National Institute of Immunology

Dr Prashant Parkash, Padma Shri, Founding Partner, Accel India; Chairman, Karnataka’s Vision Group for Startups

Dr Padmaja Ruparel, President, Indian Angel Network & Managing Partner, IAN Fund

Dr Jitendra Sharma, AMTZ Campus, Visakhapatnam

Dr Rana P. Singh, Vice Chancellor, Gautam Buddha University, Noida

Dr Sanjeev Sinha, Head, Department of Medicine, AIIMS

Dr Umakant Soni, Co-founder of ARTPARK, India’s First AI Research Translation Park

Dr Rohit Srivastava, IIT, Bombay

Dr Mrutyunjay Suar, DG R&D and Innovation, KIIT University, Bhubaneswar

Modi Prix Galien India 2024

The First edition of the Modi Prix Galien India Awards and Forum was presented by the Gujar Mal Modi Science Foundation and its President Satish Kumar Modi.

India’s Minister of Health and Family Welfare bestowed the first Modi Prix Galien Prizes, affirming the government’s strategic focus and keen emphasis on the burgeoning life science sector, writes Former DBT Secretary Dr. Manju Sharma. Read about it in CNBC.

sushruta-statue-7873BW_sm

As early as the sixth century BC, Sushruta, recognized as the “father of surgery” in ancient India, introduced pioneering operations and healing techniques.

He authored Sushruta-samhita, the first important treatise on surgery in the country providing a crucial source of information on matters of surgery, toxicology, pharmacology and pediatrics.

With its long and rich history, the India of today has the academic and scientific infrastructure, the R&D and technology transfer frameworks, the entrepreneurship and the funding to predict double digit growth rates in our current decade. It is no wonder that the world is looking at India with anticipation for new breakthroughs in health.

Prix Galien salutes the nation that has forged a formidable growth strategy in the life science sector since 1970, the year Prix Galien was founded, to become the “World’s Pharmacy” as it is often referred to today. India’s thriving life science sector represents the highest number of FDA approved production facilities outside the US and the country only continues to grow.

The Prix Galien India will be fundamental in:

Recognizing and promoting excellence and through recognition, while enhancing and encouraging a cycle of scientific research excellence and innovation.
Fostering a culture of innovation which values creative thinking, risk taking and the development of solutions that address societal challenges and contribute to economic growth.
Showcasing India’s scientific excellence and potential on the international stage.

We look forward to inducting India’s distinguished innovators to the Galien Foundation Hall of Fame in 2025. The winners will join an illustrious list of innovations benefitting human health since the prize’s inception in France in 1970. It is with pride that the Galien Foundation chronicles and honors the winning teams and encourages individuals having working on breakthrough products, devices and solution to become Foundation members and thus perpetuate the importance of their innovation to the advancement of human health.

kathleen-sebelius

“The Prix Galien USA recognizes the important research necessary to develop innovative medicines and devices that have a lifesaving impact on individuals and families across the globe.”

- Kathleen Sebelius, Former US Secretary of Health and Human Services

“I welcome you to the annual Prix Galien awards for innovative excellence in biomedical products and health technologies. The awards are among the highest honors in science and commerce.”

- Jimmy Carter, US President

“The Prix Galien is a welcome initiative to stimulate creative research and promote excellence.”

- Barack Obama, President of the United States – 2008